Clara cell secretory protein (CC16): possibility of detection in exhaled breath condensate

C. Vogelberg, S. Ruß, K. Marx, A. Böhm, A. Rösen-Wolff (Dresden, Germany)

Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Session: Noninvasive evaluation of airway diseases
Session type: Electronic Poster Discussion
Number: 528
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

Clara cell secretory protein (CC16) is secreted by Clara cells and has antiinflammatory properties within the lung. It seems to be a marker for airway epithelial injury. While increased levels of CC16 were found in broncho-alveolar lavage fluid (BALF) of patients with acute respiratory distress syndrome, reduced levels of CC 16 have been found in BALF of smokers, patients with lung cancer, COPD or asthma. The aim of the study presented was to determine whether CC16 can be measured in exhaled breath condensate and whether levels of CC16 differentiate between asthmatics and healthy controls.
Breath condensate was sampled from 15 healthy adults during 10 min of relaxed tidal breathing with a commercially available condenser (EcoScreen, JAEGER). CC16 was analysed with an ELISA (BioVendor Laboratory Medicine, Inc.) before and after lyophilisation of the sample. Further the recovery rate of the positive control within the breath condensate was analysed.
CC16 was neither detectable in the native nor in the lyophilized samples. The recovery rate of CC16 positive controls within exhaled breath condensate was good (min. 4,39 ng/ml).
The present study results suggest that exhaled breath condensate analysis is not a suitable method for detection of CC16. One reason for this might be because of concentrations below detection limit of CC16 within the condensate. This again might be due to the peripheral localisation of the clara cells within the airways.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Vogelberg, S. Ruß, K. Marx, A. Böhm, A. Rösen-Wolff (Dresden, Germany). Clara cell secretory protein (CC16): possibility of detection in exhaled breath condensate. Eur Respir J 2007; 30: Suppl. 51, 528

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Protein pattern of exhaled breath condensate (EBC) and saliva
Source: Eur Respir J 2001; 18: Suppl. 33, 461s
Year: 2001

Human skin keratins are the major proteins in exhaled breath condensate
Source: Eur Respir J 2008; 31: 380-384
Year: 2008



Keratin detected in exhaled breath condensate is an environmental contaminant
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005


Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1036-1041
Year: 2006



Protein markers in the exhaled breath condensate of lung carcinoma patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

The concentration of total protein in exhaled breath condensate (EBC) depends on various variables of ventilation
Source: Eur Respir J 2006; 28: Suppl. 50, 283s
Year: 2006

Alpha-1-antitrypsin is detectable and can be quantified in exhaled breath condensate
Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs
Year: 2008


The coating of condenser systems influences the detection of 8-isoprostane in exhaled breath condensate (EBC)
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004

Airway cytokine expression measured by protein array in exhaled breath condensate: correlation with physiological properties in asthmatic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006

Clara cell protein (CC16) as a biomarker for ozone exposure in humans
Source: Eur Respir J 2002; 20: Suppl. 38, 569s
Year: 2002

Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification
Source: Eur Respir J 2007; 30: Suppl. 51, 364s
Year: 2007

Exhaled breath condensate pH is a robust and reproducible assay of airway acidity
Source: Eur Respir J 2003 Dec 01;22(6):889-894
Year: 2003



Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 438s
Year: 2003

Proteins in exhaled breath condensate: identification and pattern
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Year: 2007


Detection of ProGRP and NSE in exhaled breath condensate (EBC) of patients with SCLC and NSCLc
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008

Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 61s
Year: 2005

Validation of assays for inflammatory mediators in exhaled breath condensate
Source: Eur Respir J 2008; 31: 943-948
Year: 2008



Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation
Source: Eur Respir J 2003; 22: 392
Year: 2003


Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004

Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007